Comparative analysis of the antiviral effects mediated by type I and III interferons in hepatitis B virus infected hepatocytes.
J. Infect. Dis. 220, 567-577 (2019)
Background. Type III interferons (IFNs) (lambda 1-3) activate similar signaling cascades as type I IFNs (alpha and beta) via different receptors. Since IFN-alpha and lymphotoxin-beta activate cytosine deamination and subsequent purging of nuclear hepatitis B virus (HBV) DNA, we investigated whether IFN-beta and -lambda may also induce these antiviral effects in differentiated HBV-infected hepatocytes.Methods. After determining the biological activity of IFN-alpha 2,-beta 1, -lambda 1, and -lambda 2 in differentiated hepatocytes, their antiviral effects were analyzed in HBV-infected primary human hepatocytes and HepaRG cells.Results. Type I and III IFNs reduced nuclear open-circle DNA and covalently closed circular DNA (cccDNA) levels in HBV-infected cells. IFN-beta and -lambda were at least as efficient as IFN-alpha. Differential DNA-denaturing polymerase chain reaction and sequencing analysis revealed G-to-A sequence alterations of HBV cccDNA in IFN-alpha, -beta, and -lambda-treated liver cells indicating deamination. All IFNs induced apolipoprotein B messenger RNA-editing enzyme-catalytic polypeptide-like (APOBEC) deaminases 3A and 3G within 24 hours of treatment, but IFN-beta and -lambda induced longer-lasting expression of APOBEC deaminases in comparison to IFN-alpha.Conclusions. IFN-beta, IFN-lambda 1, and IFN-lambda 2 induce cccDNA deamination and degradation at least as efficiently as IFN-alpha, indicating that these antiviral cytokines are interesting candidates for the design of new therapeutic strategies aiming at cccDNA reduction and HBV cure.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Hbv ; Interferon-lambda ; Interferon-beta ; Heparg Cells ; Primary Human Hepatocytes; Gene-expression; Replication; Alpha; Dna; Induction; Lambda
Keywords plus
Language
english
Publication Year
2019
Prepublished in Year
HGF-reported in Year
2019
ISSN (print) / ISBN
0022-1899
e-ISSN
1537-6613
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 220,
Issue: 4,
Pages: 567-577
Article Number: ,
Supplement: ,
Series
Publisher
Oxford University Press
Publishing Place
Journals Dept, 2001 Evans Rd, Cary, Nc 27513 Usa
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Immune Response and Infection
PSP Element(s)
G-502700-003
Grants
Copyright
Erfassungsdatum
2019-04-04